InVision Medical Technology

InVision Medical Technology utilizes AI to streamline the interpretation of ultrasounds and detect diseases that human readers might overlook. The models are seamlessly integrated into clinical workflows for easy use by clinicians. The work has been peer-reviewed and published in leading medical journals such as Nature (2020), Nature Medicine (2021), Lancet Digital Health (2021), and JAMA Cardiology (2022). Additionally, results from a blinded and randomized clinical trial on cardiac function evaluation were recently presented as a Late Breaking Clinical Trial at the European Society of Cardiology.